Bluejay Diagnostics, Inc.
BJDX · Healthcare · $952,040
After-hours $0.92-2.01%
Price
$1.20
$0.94
Jul 1, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$0M
6/'26 vs prev quarter
Company Health
Market Cap$952,040
Cash on Hand$10M1008.2% of market cap
Free Cash Flow$-6M-655.3% of market cap
Among 98 Medical - Devices peers
LowMedianHigh
PBR0.1xmedian 2.6xROE-77.2%median -26.3%Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare MarketsSep 8
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and CommercializationAug 13
Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation StudyJul 21
